Overview
Slingshot AI partners with mental health providers to develop and license AI-driven tools that support care for people worldwide. Its AI tools integrate into clinical workflows to aid assessment, monitoring, and personalized interventions, while offering patient-facing support. The company differentiates itself by collaborating with professionals and institutions and licensing its technology through healthcare partners to expand global reach. Its goal is to improve access to effective mental healthcare and patient outcomes by augmenting care delivery with AI.
Work here?Claim your company
Simplify's take
What believers are saying
- November 2026 hiring confirms Slingshot still scales engineering around Ash and evaluations.
- September 2026 pilot program targets claims and outcomes, unlocking payer revenue by 2027.
- Ash reached 500,000 users, giving Slingshot a large feedback loop and brand traction.
What critics are saying
- January 2026 UK withdrawal shows MHRA rules can shut market access fast.
- Ash is not for crisis use, leaving liability gaps during suicidal ideation episodes.
- A rival product from OpenAI, Google, or Meta can commoditize therapeutic chat within months.
What makes Slingshot AI unique
- Ash is built on a psychology foundation model, not a generic chat interface.
- Slingshot uses clinical advisors and therapist-data tuning to challenge users, not flatter them.
- The company runs 6-12 month population pilots with payers, providers, and employers.
Help us improve and share your feedback! Did you find this helpful?
Funding
Notable Investors:
Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Industry standards
Ind Avg. $15M
$3.7M
$5M
$8.2M
$13M
$15M
$30M